To be effective as of 1st May this year, Lispro will then be the lowest list-priced mealtime insulin available – less than the price of a Humalog vial back in 1999. On which point, Lilly is also ...

The company also said it would reduce the list price of unbranded insulin products to match the new lowered price of each respective branded insulin. Like Lilly, Novo Nordisk has also made a ...

Novo will drop its U.S. list price for its Fiasp by 75% ... In early 2023, shortly after Eli Lilly slashed the price of its insulin in the U.S. by 70%, Novo Nordisk and Sanofi quickly followed ...

Insulin makers Eli Lilly & Co. Sanofi and Novo Nordisk “have sharply inflated the list price of their insulin products in ...